WO2000076421A1 - Device for delivery of a liquid vehicle - Google Patents

Device for delivery of a liquid vehicle Download PDF

Info

Publication number
WO2000076421A1
WO2000076421A1 PCT/NZ2000/000093 NZ0000093W WO0076421A1 WO 2000076421 A1 WO2000076421 A1 WO 2000076421A1 NZ 0000093 W NZ0000093 W NZ 0000093W WO 0076421 A1 WO0076421 A1 WO 0076421A1
Authority
WO
WIPO (PCT)
Prior art keywords
device
liquid
electrical circuit
outlet
housing
Prior art date
Application number
PCT/NZ2000/000093
Other languages
French (fr)
Inventor
Craig Robert Bunt
Michael John Rathbone
Shane Burggraaf
Original Assignee
Interag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to NZ33624199A priority Critical patent/NZ336241A/en
Priority to NZ336241 priority
Application filed by Interag filed Critical Interag
Publication of WO2000076421A1 publication Critical patent/WO2000076421A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61DVETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D7/00Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals

Abstract

An intra vaginal delivery device for a target species mammal comprising or including: an elongate housing defining a barrel with an outlet at one end (the 'outlet end'); a piston disposed in said barrel and moveable towards the outlet end to reduce the available volume for liquid between said piston and said outlet; a progesterone including liquid within said barrel between said outlet and said piston, the volume of such liquid preferably being from 5 to 100 mL; wings dependent from said housing capable of self depployment from a vaginal tract insertion condition to assume a vaginal tract retention geometry for the target species mammal; a battery powered electrical circuit disposed in said housing at the non outlet end region thereof capable of being initialised in order to energise the electrical circuit from the battery thereof, such battery (or an electrolytic cell forming part of the circuit) generating, once the electrical circuit is energised, at least one gas confined within said housing, such gas being capable when in sufficient quantities to move said piston along said barrel thereby to express said liquid out through said outlet.

Description

DEVICE FOR DELIVERY OF A LIQUID VEHICLE

THE CURRENT INVENTION

The present invention relates to improvements in the delivery of an active agent into an environment (whether in vivo or in vitro) and particularly, although not solely, to devices having application in the delivery of one or more active ingredients into a mammal (eg; intra ruminally or intra vaginally) or into an aqueous environment, e.g. an aquarium.

SUMMARY OF THE INVENTION

In our PCT NZ98/00011 we disclose in some detail the background to the passive and active release of active ingredient(s) into the body cavity of mammals including the vaginal tract and the rumen. PCT/NZ96/00024 (WO 96/29025) discloses a microprocessor controlled active release device for intra vaginal insertion with its retention being dependent on variable geometries possible using deployment members of a kind as disclosed in NZ Patent Specifications 193976 and 200564.

A problem discussed in such specification is the release profile of a substance delivery device whether for a body cavity or otherwise (for example, a liquid body such as an aquarium) arising from a passive leakage of material which can affect the overall release profile.

We have investigated different known procedures of active release and have considered new procedures insofar as the means of expression of a liquid vehicle from a reservoir of reducible volume is concerned. It is to such substance delivery devices and their use that the present invention is directed. In a first aspect the present invention consists in a (preferably body cavity) liquid delivery device comprising or including a housing defining a barrel with an outlet, a piston disposed in said barrel and moveable to reduce the available volume for liquid between said piston and said outlet, a liquid within said barrel between said outlet and said piston, and a battery powered electrical circuit disposed in said housing capable of being energised to generate gas or gases confined within said housing yet capable of moving said piston along said barrel thereby to express liquid out through said outlet.

Preferably the battery itself of said electrical circuit emits said gas or gases upon energisation of the electrical circuit by said battery. In another form said electrical circuit defines an electrolysis cell with a hydrogel or electrolyte and the gas issues or gases issue from said hydrogel or electrolyte.

Preferably the battery powered electrical circuit includes a battery of a kind as disclosed in US Patent 5,242,565.

Preferably said battery powered electrical circuit, where an electrolysis cell is involved, includes an electrolysis cell of a kind as disclosed in US Patent 5,352,464.

Preferably said electrical circuit provides a continuous rate of gas production by the action of a continuous current to the electrolysis cell or gas emitting battery.

Alternatively said electrical circuit provides a discontinuous rate of gas production by the action of a discontinuous current, for example, as might be provided by a microprocessor, to the electrolysis cell or gas emitting battery.

Preferably where said battery powered electrical circuit provides a continuous rate of gas production, such production is dependent upon at least one of the group consisting of

(a) a selected resistor in series, (b) a selected variable resistor and a setting of a desired resistance in series, and

(c) a selected microprocessor to control the current.

Preferably the battery powered electrical circuit is one having a known or calibrated profile of gas generation that will lead to a related profile of liquid release from said outlet.

Preferably said device is an intra vaginal device .

Preferably said housing has associated therewith at least one deployable retention member to enable the retention of the device in the vagina after insertion in the vagina of a target mammal whilst said at least one retention member is not deployed. Preferably said at least one retention member comprises at least two wings which resiliently deploy once inserted and preferably are no longer restrained by an insertion tool.

Preferably the retention feature(s) is (are) those typified in the disclosure of PCT/NZ97/00052, PCT/NZ98/00011 and PCT/NZ98/00024 (and any specification referred to therein), the full content of which is hereby here incorporated by way of reference.

Preferably said liquid includes progesterone in an appropriate liquid carrier.

In another embodiment said device is an intra ruminal device.

Preferably said intra ruminal device is retainable in the rumen of a target mammal by means of its density (at least up until the depletion of the liquid from said housing) or by deployment of at least one retention member.

Preferably said liquid includes at least one or more of water, ethanol and benzyl alcohol.

Preferably said battery powered electrical circuit includes a switch capable of being actuated immediately or after a delay to commence the generation of a gas or gases.

Preferably said outlet is provided with a closure capable of being removed or ruptured or dissolved in body fluids.

Preferably said closure is capable of being removed or ruptured under the pressurisation of the liquid within said housing upon energisation of the battery powered electrical circuit.

Preferably said liquid is of a volume of from 5 to 100 mL and said piston is movable within said housing to express substantially all of such liquid from the housing.

Preferably said device is insertable, retainable and removal from the vaginal tract of a target species mammal, there being a conduit or passageway disposed to allow pressure equalisation outside of the device at the innermost and outmost extent of the device in the vaginal tract.

Preferably said device is substantially as hereinafter described with reference to the accompanying drawings.

In still another aspect the invention consists in an intra vaginal delivery device comprising or including a housing defining a barrel with an outlet, variable geometry vaginal retention means carried by said housing, a piston disposed in said barrel and moveable to reduce the available volume for liquid between said piston and said outlet, a progesterone carrying liquid within said barrel between said outlet and said piston, and a battery powered electrical circuit disposed in said housing capable of being energised to generate gas or gases from the battery of said battery powered electrical circuit, such generated gas or gases being confined within said housing and being capable of moving said piston along said barrel thereby to express liquid out through said outlet and wherein said battery powered electrical circuit provides a discontinuous or continuous gas production upon initiation of energisation with rate and/or timing dependent upon at least one of the group consisting of

(a) a selected resistor in series, (b) a selected variable resistor and a setting of a desired resistance in series, and

(c) a selected microprocessor to control the current.

In still a further aspect the present invention consists in an intra vaginal delivery device comprising or including an elongate housing defining a barrel with an outlet at one end (the "outlet end"), a piston disposed in said barrel and moveable towards the outlet end to reduce the available volume for liquid between said piston and said outlet, a progesterone including liquid within said barrel between said outlet and said piston, the volume of such liquid being from 5 to 100 mL, wings dependent from said housing capable of self deployment from a vaginal tract insertion condition to assume a vaginal tract retention geometry for the target species mammal, a battery powered electrical circuit disposed in said housing at the non outlet end region thereof capable of being initialised in order to energise the electrical circuit from the battery thereof, such battery generating once the electrical circuit is energised at least one gas confined within said housing, such gas being capable when in sufficient quantities to move said piston along said barrel thereby to express said liquid out through said outlet.

In another aspect the invention consists in a method of providing an active release of a liquid within a body cavity of a target species mammal which comprises or includes locating in such a body cavity a device as claimed in any one of the preceding claims with said battery powered electrical circuit energised or committed to be energised.

In still another aspect the invention consists in a method of delivering an active amount of a progesterone into the vaginal tract of a target species mammal which comprises locating a device of the present invention in such tract after initiation of the device, and allowing the device to actively express the liquid from said housing under the effect, via said piston, of the gas or gases generated by the energised battery powered electrical circuit.

Preferably said method involves removing said device after a sufficient time of liquid delivery.

In another aspect the invention is a method when performed substantially as herein described with or without reference to any one or more of the accompanying drawings.

In still other aspects the present invention consists in a method of providing a delayed release of a liquid vehicle into a body cavity of a mammal or into a liquid environment or other environment which comprises the operative use of a delivery device in accordance with the present invention. Preferably said devices do not include a dip tube or the equivalent of a kind as defined in, for example, PCT/NZ98/00011.

In still a further aspect the present invention consists in an intra ruminal device which is also a delivery device in accordance with the present invention.

In still a further aspect the present invention consists in an intra vaginal device which is also a delivery device in accordance with the present invention.

In still a further aspect the present invention consists in any of the devices or apparatus previously defined whereby means is provided to enable for equalisation of pressures between the zone externally adjacent said outlet with some region of the device having a closer access to ambient condition when the device is retained in a body cavity, such means providing for fluid (preferably gas and preferably air) communication to minimise pressure differentials adjacent the outlet as a result of movement of walls of the body cavity and an air seal about the device in the body cavity.

Preferably the arrangement is of any kind typified by the diagrammatic form shown in, for example, Figure 5.

BRIEF DESCRIPTION OF THE DRAWINGS

Preferred forms of the present invention will now be described with reference to the accompanying drawings in which;

Figure 1A shows a balloon or membrane containing embodiment of a device, Figure IB is a piston including syringe-like embodiment,

Figure 2 is a plot for the Figure 1A and B embodiments of volume released against time,

Figure 3 compares for the Figures 1 A device the in vivo and in vitro delivery profiles with a plot of volume release against time, Figure 4 is a similar comparison for the Figure IB device plotted in a similar fashion to that of Figure 3,

Figure 5 shows how (in this case for the more energy demanding but better in vivo delivery profile device - that of Figure IB) the use of a tube whereby the transient pressure differentials (eg; in the vaginal tract) adjacent the outlet may be reduced, Figure 6 is a plot of the plasma progesterone following intra vaginal insertion of a device of Figure 1A,

Figure 7 is a plot of the plasma progesterone following intra vaginal insertion of a device of Figure IB with three different progesterone formulations,

Figures 8A through 8D show a simple circuit diagram each involving an electrolytic cell, Figure 8A shows an electrolytic cell in series with resistor and power source, Figure 8B shows an electrolytic cell in series with a variable resistor and power source, Figure 8C shows an electrolytic cell controlled by powered microprocessor and Figure 8D shows an electrolytic cell controlled by powered microprocessor,

Figure 9A through 9D show a series of different circuits appropriate where a battery of a kind capable of generating a gas or gases is utilised in the circuit, Figure 9A showing a gas cell of the type described by US Patent 5,242,565 in series with a resistor, Figure 9B shows a gas cell of the type described by US Patent 5,242,565 in series with a variable resistor, Figure 9C shows a gas cell of the type described by US Patent 5,242,565 controlled by a gas cell of the type described by US Patent 5,242,565 powered microprocessor and Figure 9D shows a gas cell of the type described by US Patent 5,242,565 controlled by a microprocessor powered by an external power source, and

Figure 10A shows in broken outline two insertion conditions for self deployable wings and Figure 10B shows such wings deployed to a vaginal tract retention condition.

DETAILED DESCRIPTION OF THE INVENTION

The present invention recognises advantages that might flow to particularly body cavity retainable devices (eg; intra vaginal or intra ruminal devices) where a liquid vehicle is to be actively released and there is a desire to reduce the ratio of passive release to active release. In this respect embodiments to be discussed hereinafter recognise advantages that arise from the use of gas generation for the purposes of reducing the available volume in a reservoir for the liquid vehicle to be expressed.

For low energy usage preferably an inflatable device as hereinafter described by reference to Figure 1 is preferred yet surprisingly as will hereinafter be described we have determined that a plunger or piston like reservoir reduction provides a better in vivo release profile over that of the inflation option owing to a reduction in passive delivery. Where therefore rapid release with some passive content is not of concern significant energy savings are available for an active release device utilising the inflation option. Where however controlled release is of primary importance and/or there is no concern with an initial startup delay or a startup delay is desired the option hereinafter described by reference to Figure IB with the use of a gas generated battery is to be preferred even though it will be a higher energy requirement for such an option.

The devices of Figures 1A and IB utilize electronically controlled gas to facilitate the delivery of a vehicle. The vehicle may be aqueous, organic or non-organic based. The production of gas may be from a suitable electrolytic material (US5352464) or galvanic cell (US 5242565) and is controlled by suitable circuitry.

The device of Figure 1 A incorporates a balloon that upon the production of gas and its movement into the balloon means the balloon expands to fill the reservoir containing the liquid vehicle. This expansion results in the delivery of the liquid vehicle out of the outlet. The device of Figure IB incorporates a piston that upon the production of gas behind the piston results in its migration towards the outlet. This forward migration results in the delivery of the liquid vehicle.

In Figure 1 A the balloon 1 is disposed within a syringe like reservoir 2 having an outlet 3. The liquid vehicle 4 is interposed between the walls of the reservoir 2 the outlet 3 and the balloon 1 so that inflation thereof will have the effect of expressing the liquid vehicle 4 out of the outlet 3. The inflation is by means of electronic gas production at 5 which feeds gas via an appropriate conduit 6 to the confines of the balloon or diaphragm 1. Such conduit is indicated as 6.

The arrangement as in Figure IB is much the same save that instead of the balloon or membrane 1 , a piston 7 is provided which will move to reduce the volume for the liquid vehicle 4 therebetween and the outlet 3.

In use when both devices of Figures 1 A and IB are operated with the same rate of gas production the arrangement as shown in Figure 1A with the inflatable balloon allows for a more rapid onset of delivery with a greater flow of vehicle compared to the piston arrangement which is characterised by a lag in the onset of delivery and a reduced delivery rate.

Accordingly for some applications the device of Figure 1 offers advantages over a device of Figure IB. In the plot of Figure 2, the lag in the onset of delivery from the configuration of Figure IB is readily apparent from the lower line on the graph, Preferably the control circuitry involves a resistor (variable or otherwise) of an appropriate kind to affect the current flow. The circuitry may optionally be microprocessor controlled.

The liquid vehicle is preferably at least primarily aqueous, organic or non- organic as far as its liquid content is concerned. Whilst in preferred forms the vehicle as a whole may be viewed overall as a liquid it need not necessarily be a solution. The liquid itself may be the active or merely a liquid carrier for the active elsewhere in the vehicle.

Accordingly, the term "liquid vehicle" or "liquid" should be interpreted as including any one or more of a suspension, a dispersion, an emulsion, a susproemulsion, a solution and the like, and preferably a progesterone including "liquid". Whilst the arrangement of Figure 1A has definite efficiencies in respect of the energisation required for the purpose of gas generation per volume of liquid vehicle dispensed and the lack of delay in such dispensation, the device of a kind shown in Figure IB has been found to improve the delivery of liquid vehicle whilst inserted into a body cavity such as the rumen or the vaginal cavity. Figure 3 shows a plot of liquid vehicle delivered in grams against time and days with a device as depicted in Figure 1 A. The straighter line is the in vitro delivery of vehicle from a device of Figure 1 A whilst the more curved line represents the in vivo delivery profile for an identical device. It is therefore surprising that whilst a device as shown in Figure 1 A has the comparative in vitrolin vivo profiles shown in Figure 3, that a device as shown in Figure IB has more agreement between the in vitrolin vivo profiles. In this respect see Figure 4 where in a similar way to that of Figure 3 the comparative performance of a device as in Figure IB is shown in the in vitro and in vivo delivery modes. That line indicated with the shaded squares represents the in vivo profile. For the purpose of the generation of the data shown in Figures 3 and 4 the volume of liquid vehicle being dispensed was in each case water to be expressed out of a 2 mm diameter outlet. In each case the syringe like reservoir was of a cylindrical form and was powered over the duration of the comparative trials by a galvanic cell of the kind disclosed in US Patent 5242565 capable of generating over the life of the cell to depletion up to 180 ml of hydrogen when measured at normal atmospheric conditions at sea level. Figure 5 shows a variation of the device as shown in Figure 1A. In this form means is provided to reduce variations at least over the medium term in the pressure differential in a body cavity with that of the ambient atmosphere. For this purpose a tube 8 is provided which, in the case of an intra vaginal device as shown in Figure 5 (the variable geometry wings not being shown for convenience, but do see our PCT/NZ97/00052 (published as WO97/40776)) tends to equilibralise pressure externally of the device in a vaginal tract. Indeed the tube 8 if flexible may serve in part as a withdrawal mechanism for the device and as a passageway 9 through to an outlet zone 10. Experimentation with, for example, cattle has shown in the short to medium terms significant fluctuations in the pressure about the outlet of devices of the kind shown in Figures 1A and IB which have the effect of providing a different net force acting on the liquid vehicle yet to be expressed. This is particularly disadvantageous with the device of Figure 1 A where there is (as demonstrated in Figure 2) a more rapid onset of delivery following any adjustment in pressure on the liquid vehicle. Accordingly, the device of Figure IB has a better profile under variations of vaginal tract pressure without any arrangement that seeks to reduce localised pressure variations externally of the device.

Description of the technology: The devices depicted in Figures 1A and IB utilize electronically controlled gas

5 to facilitate the delivery of a vehicle. The vehicle may be aqueous, organic or non- organic based. The production of gas may be from a suitable electrolytic material (US 5354264) or galvanic cell (US 5242565) and is controlled by suitable circuitry.

The top device of Figure 1 A incorporates a balloon that upon the production of gas within 6 the balloon 1 expands to fill the reservoir 2 containing a vehicle 4. This expansion results in the delivery of the liquid vehicle out of the outlet 3.

The bottom device of Figure IB incorporates a piston 7 that upon the production of gas behind 6 the piston results in its migration towards the outlet. This forward migration results in the delivery of vehicle. Figure 3 shows both the in vitro and in vivo delivery of vehicle from a body cavity for the device of Figure 1A. Figure 4 shows the in vitro and in vivo agreement of vehicle delivered for the device of Figure IB.

The device of Figure 5 utilizes electronically controlled gas to facilitate the delivery of a vehicle. The vehicle may be aqueous, organic or non-organic based. The production of gas may be from a suitable electrolytic material (US 5354264) or galvanic cell (US 5242565) and is controlled by suitable circuitry.

The device of Figure 5 shows improvements to enable a more controlled delivery of vehicle to a body cavity. The addition of a tube 9 (or indeed any passageway from one end to the other) facilitates the maintenance of a constant pressure within the cavity 10 in relation to the exterior pressure 8.

Example 1:

Formulation: Progesterone 15 mg/ml dissolved in ethanol. Device: As shown in Figure 1 A Comment: Delivery profile characterised by a dose dump soon after insertion, followed by a reduction in plasma progesterone delivery on day due to the dose dump. See Figure 6. Figure 6 shows a plot of plasma progesterone concentration following the intra vaginal insertion of a device as per Figure 1 A. Error bars are standard error means.

Example 2:

Formulation 1 : Progesterone 15 mg/ml dissolved in ethanol.

Formulation 2: Progesterone 15 mg/ml suspended in water.

Formulation 3: Progesterone 15 mg/ml dissolved in hydroxypropyl b-cyclodextrin

(20%w/v) solution. Device: As shown in Figure IB.

Comment: Delivery profile characterised by a rapid rise to desired levels soon after insertion, followed by a controlled delivery of progesterone over the remained of the insertion period. See Figure 7. Figure 7 shows a plot of the plasma progesterone concentration following the intra vaginal insertion of a device as per Figure IB containing 1 of 3 formulations; alcoholic solution (diamond symbol), aqueous suspension (triangle symbol with broken line) or aqueous cyclodextrin (square symbol). Error bars are standard error means.

Figures 8A to 8D and Figures 9A to 9D describe options available for circuits where respectively (Figures 8A to 8D) and electrolytic cell and (Figures 9A to 9D) a battery or gas cell of the type described by US Patent 5,242,565 is used. Appropriate electrolytic cell is that using, for example, a hydrogel as disclosed in US Patent

5,354,264.

The present invention as can be seen from the disclosure and the drawings (including those of the prior art referenced earlier in respect of vaginal tract retention features) can be used to deliver progesterone requirements prior to active withdrawal to allow the onset of oestrus. Again reference is drawn to such art as to insertion, retention options and withdrawal facilitating options.

Claims

CLAIMS:
1. A liquid delivery device suitable for liquid delivery in a body cavity when inserted therein, said comprising or including a housing defining a barrel with an outlet, a piston disposed in said barrel and moveable to reduce the available volume for liquid between said piston and said outlet, a liquid within said barrel between said outlet and said piston, and a battery powered electrical circuit disposed in said housing capable of being energised to generate gas or gases confined within said housing yet capable of moving said piston along said barrel thereby to express liquid out through said outlet.
2. A device as claimed in claim 1 wherein the battery itself of said electrical circuit emits said gas or gases upon energisation of the electrical circuit by said battery.
3. A device as claimed in claim 1 wherein said electrical circuit defines an electrolysis cell with a hydrogel or electrolyte and the gas issues or gases issue from said hydrogel or electrolyte.
4. A device as claimed in claim 2 wherein the battery powered electrical circuit includes a battery of a kind as disclosed in US Patent 5,242,565.
5. A device as claimed in claim 3 wherein said battery powered electrical circuit includes an electrolysis cell of a kind as disclosed in US Patent 5,352,464.
6. A device of any one of the preceding claims wherein said electrical circuit provides a continuous rate of gas production by the action of a continuous current to the electrolysis cell or gas emitting battery.
7. A device of any one of claims 1 to 5 wherein said electrical circuit provides a discontinuous rate of gas production by the action of a discontinuous current, as provided by a microprocessor, to the electrolysis cell or gas emitting battery.
8. A device of claim 6 wherein said battery powered electrical circuit provides a continuous rate of gas production dependent upon at least one of the group consisting of
(a) a selected resistor in series, (b) a selected variable resistor and a setting of a desired resistance in series, and (c) a selected microprocessor to control the current.
9. A device as claimed in claim 7 wherein said battery powered electrical circuit includes a selected microprocessor to control the current to the electrolysis cell or gas emitting cell.
10. A device as claimed in any one of the preceding claims wherein the battery powered electrical circuit is one having a known or calibrated profile of gas generation that will lead to a related profile of liquid release from said outlet.
11. A device as claimed in any one of the preceding claims which is an intra vaginal device.
12. A device as claimed in claim 1 1 wherein said housing has associated therewith at least one deployable retention member to enable the retention of the device in the vagina after insertion in the vagina of a target mammal whilst said at least one retention member is not deployable.
13. A device as claimed in claim 12 wherein said at least one retention member comprises at least two wings which resiliently deploy once inserted.
14. A device as claimed in any one of the preceding claims wherein said liquid includes progesterone in an appropriate liquid carrier.
15. A device as claimed in any one of claims 1 to 10 which is an intra ruminal device.
16. A device as claimed in claim 15 wherein said intra ruminal device is retainable in the rumen of a target mammal by means of its density at least up until the depletion of the liquid from said housing or by deployment of at least one retention member.
17. A device as claimed in any one of the preceding claims wherein said liquid includes at least one or more of water, ethanol and benzyl alcohol.
18. A device as claimed in any one of the preceding claims wherein said battery powered electrical circuit includes a switch capable of being actuated to immediately or after a delay commence the generation of a gas or gases.
19. A device as claimed in any one of the preceding claims wherein said outlet is provided with a closure capable of being removed, ruptured or dissolved in body fluids.
20. A device as claimed in claim 19 wherein said closure is capable of being removed or ruptured under the pressurisation of the liquid within said housing upon energisation of the battery powered electrical circuit.
21. A device as claimed in any one of the preceding claims wherein said liquid is of a volume of from 5 to 100 mL and said piston is movable within said housing to express substantially all of such liquid from the housing.
22. A device of any one of the preceding claims insertable, retainable and removal from the vaginal tract of a target species mammal, there being a conduit or passageway disposed to allow pressure equalisation outside of the device at the innermost and outmost extent of the device in the vaginal tract.
23. A device as claimed in any one of the preceding claims substantially as hereinbefore described with reference to the accompanying drawings.
24. An intra vaginal delivery device comprising or including a housing defining a barrel with an outlet, variable geometry vaginal retention means carried by said housing, a piston disposed in said barrel and moveable to reduce the available volume for liquid between said piston and said outlet, a progesterone carrying liquid within said barrel between said outlet and said piston, and a battery powered electrical circuit disposed in said housing capable of being energised to generate gas or gases from the battery of said battery powered electrical circuit, such generated gas or gases being confined within said housing and being capable of moving said piston along said barrel thereby to express liquid out through said outlet and wherein said battery powered electrical circuit provides a discontinuous or continuous gas production upon initiation of energisation with rate and/or timing dependent upon at least one of the group consisting of
(a) a selected resistor in series,
(b) a selected variable resistor and a setting of a desired resistance in series, and
(c) a selected microprocessor to control the current.
25. An intra vaginal delivery device for a target species mammal comprising or including -loan elongate housing defining a barrel with an outlet at one end (the "outlet end") a piston disposed in said barrel and moveable towards the outlet end to reduce the available volume for liquid between said piston and said outlet, a progesterone including liquid within said barrel between said outlet and said piston, the volume of such liquid being from 5 to 100 mL, wings dependent from said housing capable of self deployment from a vaginal tract insertion condition to assume a vaginal tract retention geometry for the target species mammal, a battery powered electrical circuit disposed in said housing at the non outlet end region thereof capable of being initialised in order to energise the electrical circuit from the battery thereof, such battery generating once the electrical circuit is energised at least one gas confined within said housing, such gas being capable when in sufficient quantities to move said piston along said barrel thereby to express said liquid out through said outlet.
26. A method of providing an active release of a liquid within a body cavity of a target species mammal which comprises or includes locating in such a body cavity a device as claimed in any one of the preceding claims with said battery powered electrical circuit energised or committed to be energised.
27. A method of delivering an active amount of a progesterone into the vaginal tract of a target species mammal which comprises or includes locating a device as claimed in any one of claims 1 to 25 in such tract after initiation of the device, and allowing the device to actively express the liquid from said housing under the effect, via said piston, of the gas or gases generated by the energised battery powered electrical circuit.
28. A method as claimed in claim 27 wherein said method involves removing said device after a sufficient time of liquid delivery.
29. A method of providing delayed release of a liquid vehicle into a body cavity of a mammal or into a liquid environment which comprises or includes the operative use of a device of any one of claims 1 to 25.
30. A method as claimed in any one of claims 26 to 29 when performed substantially as hereinbefore described with or without reference to any one or more of the accompanying drawings.
PCT/NZ2000/000093 1999-06-11 2000-06-09 Device for delivery of a liquid vehicle WO2000076421A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NZ33624199A NZ336241A (en) 1999-06-11 1999-06-11 Liquid delivery device, typically in form of bolus, with battery powered circuit to generate gas and move piston to expel gas
NZ336241 1999-06-11

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA 2376872 CA2376872A1 (en) 1999-06-11 2000-06-09 Device for delivery of a liquid vehicle
AU49601/00A AU775581B2 (en) 1999-06-11 2000-06-09 Device for delivery of a liquid vehicle
EP20000931771 EP1200009A1 (en) 1999-06-11 2000-06-09 Device for delivery of a liquid vehicle

Publications (1)

Publication Number Publication Date
WO2000076421A1 true WO2000076421A1 (en) 2000-12-21

Family

ID=19927329

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NZ2000/000093 WO2000076421A1 (en) 1999-06-11 2000-06-09 Device for delivery of a liquid vehicle

Country Status (5)

Country Link
EP (1) EP1200009A1 (en)
AU (1) AU775581B2 (en)
CA (1) CA2376872A1 (en)
NZ (1) NZ336241A (en)
WO (1) WO2000076421A1 (en)

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ193976A (en) 1980-06-09 1984-10-19 Ahi Operations Ltd Intra-vaginal device and manufacture thereof,active ingredient in polymeric coating
NZ200564A (en) 1982-05-10 1987-03-06 Ahi Operations Ltd Device for slowly releasing chemicals into body cavities of animals
US5242565A (en) * 1989-07-10 1993-09-07 August Winsel Device for electrochemical generation of gases for the transportation of fluids and similar mediums
WO1994001165A1 (en) * 1992-07-13 1994-01-20 Elan Medical Technologies Limited Medication administering device
US5352464A (en) 1990-04-17 1994-10-04 Fundokin Shoyu Kabushiki Kaisha Process for the manufacture of salt-free, condensed seasoning powder
WO1996029025A1 (en) * 1995-03-23 1996-09-26 Advanced Animal Technology Limited Substance delivery device
WO1997040776A1 (en) 1996-05-01 1997-11-06 Dec International Nz Limited Synchronising of animal oestrus and intra vaginal devices useful therein
WO1998033452A1 (en) * 1997-02-03 1998-08-06 Dec International Nz Limited Active delivery device and related procedures
WO1998037414A1 (en) 1997-02-21 1998-08-27 New Zealand Dairy Board Immune response diagnostic test
WO1999007346A1 (en) * 1997-08-07 1999-02-18 Microlin, L.C. Implantable gas propelled beneficial agent delivery device

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ193976A (en) 1980-06-09 1984-10-19 Ahi Operations Ltd Intra-vaginal device and manufacture thereof,active ingredient in polymeric coating
NZ200564A (en) 1982-05-10 1987-03-06 Ahi Operations Ltd Device for slowly releasing chemicals into body cavities of animals
US5242565A (en) * 1989-07-10 1993-09-07 August Winsel Device for electrochemical generation of gases for the transportation of fluids and similar mediums
US5352464A (en) 1990-04-17 1994-10-04 Fundokin Shoyu Kabushiki Kaisha Process for the manufacture of salt-free, condensed seasoning powder
WO1994001165A1 (en) * 1992-07-13 1994-01-20 Elan Medical Technologies Limited Medication administering device
WO1996029025A1 (en) * 1995-03-23 1996-09-26 Advanced Animal Technology Limited Substance delivery device
WO1997040776A1 (en) 1996-05-01 1997-11-06 Dec International Nz Limited Synchronising of animal oestrus and intra vaginal devices useful therein
WO1998033452A1 (en) * 1997-02-03 1998-08-06 Dec International Nz Limited Active delivery device and related procedures
WO1998037414A1 (en) 1997-02-21 1998-08-27 New Zealand Dairy Board Immune response diagnostic test
WO1999007346A1 (en) * 1997-08-07 1999-02-18 Microlin, L.C. Implantable gas propelled beneficial agent delivery device

Also Published As

Publication number Publication date
AU775581B2 (en) 2004-08-05
NZ336241A (en) 2001-12-21
CA2376872A1 (en) 2000-12-21
EP1200009A1 (en) 2002-05-02
AU4960100A (en) 2001-01-02

Similar Documents

Publication Publication Date Title
Parker et al. Inhibition by Ca2+ of inositol trisphosphate-mediated Ca2+ liberation: a possible mechanism for oscillatory release of Ca2+
JP4162594B2 (en) Electronic control system and process for electromagnetic pump
US6042704A (en) Storage-stable, fluid dispensing device using a hydrogen gas generator
Kendall The delivery of particulate vaccines and drugs to human skin with a practical, hand-held shock tube-based system
Bernardi et al. Combination of 1α, 25-dihydroxyvitamin D3 with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling
EP0980280B1 (en) Drug delivery and gene therapy delivery system
KR20090051246A (en) Needle-free injector device with autoloading capability
US4902278A (en) Fluid delivery micropump
US6350259B1 (en) Selected drug delivery profiles using competing ions
US4140122A (en) Implantable dosing device
US7322974B2 (en) TUNA device with integrated saline reservoir
US20080033338A1 (en) Electroosmotic pump apparatus and method to deliver active agents to biological interfaces
Byskov Ultrastructural studies on the preovulatory follicle in the mouse ovary
TW587050B (en) Pre-filled disposable pipettes
US20080262491A1 (en) Tuna Device with Integrated Saline Reservoir
EP0865773A1 (en) Catheter deliverable coiled wire thrombogenic apparatus and method
DE69827249T2 (en) Electrochemically driven syringe pump
Cooke et al. Uterine glands: development, function and experimental model systems
US20070003596A1 (en) Drug depot for parenteral, in particular intravascular, drug release
US5354264A (en) Gas pressure driven infusion system by hydrogel electrolysis
CA1047402A (en) Intra-uterine device
US20020114803A1 (en) Compositions and methods for enhancing receptor-mediated cellular internalization
KR101731227B1 (en) Methods and apparatus for buffering anesthetics
CN1198601C (en) Osmotic delivery system flow modulator appts.
US20060177573A1 (en) Coating medical devices

Legal Events

Date Code Title Description
AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase in:

Ref country code: CA

Ref document number: 2376872

Kind code of ref document: A

Format of ref document f/p: F

Ref document number: 2376872

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 49601/00

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2000931771

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09926745

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2000931771

Country of ref document: EP

NENP Non-entry into the national phase in:

Ref country code: JP

WWG Wipo information: grant in national office

Ref document number: 49601/00

Country of ref document: AU

WWW Wipo information: withdrawn in national office

Ref document number: 2000931771

Country of ref document: EP